VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
ivermectin and albendazole
Preclinical
Small molecule
D
DBL -Institute for Health Research and Development
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Infection
1 trial
Epidemiology and Control of Mansonella Perstans Infection in Uganda
Completed
·
D
DBL -Institute for Health Research and Development
·
N/A
·
NCT00215280
·
1,000 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for ivermectin and albendazole. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
ivermectin and albendazole compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for ivermectin and albendazole. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
DBL -Institute for Health Research and Development company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
D
DBL -Institute for Health Research and Development
Related News